全文获取类型
收费全文 | 1935篇 |
免费 | 101篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 35篇 |
妇产科学 | 7篇 |
基础医学 | 278篇 |
口腔科学 | 57篇 |
临床医学 | 108篇 |
内科学 | 519篇 |
皮肤病学 | 22篇 |
神经病学 | 158篇 |
特种医学 | 29篇 |
外科学 | 319篇 |
综合类 | 5篇 |
预防医学 | 56篇 |
眼科学 | 35篇 |
药学 | 137篇 |
中国医学 | 3篇 |
肿瘤学 | 266篇 |
出版年
2023年 | 9篇 |
2022年 | 12篇 |
2021年 | 32篇 |
2020年 | 26篇 |
2019年 | 25篇 |
2018年 | 49篇 |
2017年 | 27篇 |
2016年 | 43篇 |
2015年 | 28篇 |
2014年 | 47篇 |
2013年 | 48篇 |
2012年 | 73篇 |
2011年 | 90篇 |
2010年 | 75篇 |
2009年 | 43篇 |
2008年 | 73篇 |
2007年 | 85篇 |
2006年 | 68篇 |
2005年 | 62篇 |
2004年 | 85篇 |
2003年 | 88篇 |
2002年 | 91篇 |
2001年 | 80篇 |
2000年 | 84篇 |
1999年 | 74篇 |
1998年 | 24篇 |
1997年 | 12篇 |
1996年 | 17篇 |
1995年 | 14篇 |
1994年 | 15篇 |
1993年 | 12篇 |
1992年 | 45篇 |
1991年 | 52篇 |
1990年 | 51篇 |
1989年 | 49篇 |
1988年 | 32篇 |
1987年 | 40篇 |
1986年 | 42篇 |
1985年 | 27篇 |
1984年 | 30篇 |
1983年 | 25篇 |
1982年 | 13篇 |
1981年 | 8篇 |
1979年 | 16篇 |
1978年 | 12篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1975年 | 8篇 |
1973年 | 8篇 |
1966年 | 7篇 |
排序方式: 共有2038条查询结果,搜索用时 31 毫秒
61.
I. Ninomiya H. Osugi T. Fujimura S. Fushida K. Okamoto S. Maruzen K. Oyama J. Kinoshita T. Tsukada H. Kitagawa H. Takamura H. Nakagawara H. Tajima H. Hayashi I. Makino T. Ohta 《Diseases of the esophagus》2014,27(2):159-167
The aim of this study was to estimate the technical and oncologic feasibility of video‐assisted thoracoscopic radical esophagectomy (VATS) in the left lateral position. From January 2003 to December 2011, 132 patients with esophageal cancer underwent VATS. The mean duration of the thoracic procedure and the entire procedure was 294 ± 88 and 623 ± 123 minutes, respectively. Mean blood loss during the thoracic procedure and the entire procedure was 313 ± 577 and 657 ± 719 g, respectively. The mean number of dissected thoracic lymph nodes was 32.6 ± 12.9. There were four in‐hospital deaths (3.0%); two patients (1.5%) died of acute respiratory distress syndrome and two patients (1.5%) died of tumor progression. Postoperative unilateral or bilateral recurrent laryngeal nerve (RLN) palsy, or pneumonia was found in 33 (25.0%), 21 (15.9%), and 27(20.5%) patients, respectively. The patients were divided into the first 66 patients who underwent VATS (Group 1) and the subsequent 66 patients (Group 2). The numbers of cases who underwent neoadjuvant or induction chemotherapy for T4 tumor and intrathoracic anastomosis were higher in Group 2 than in Group 1. The duration of the procedure, amount of blood loss, and the number of dissected thoracic lymph nodes were not different between the two groups. The total number of dissected lymph nodes was higher in Group 2 than in Group 1 (72.6 ± 27.8 vs. 62.6 ± 21.6, P = 0.023). The rate of bilateral RLN palsy was less in Group 2 than in Group 1 (7.6% vs. 24.2%, P = 0.042). The mean follow‐up period was 38.7 months. Primary recurrence consisted of hematogenous, lymphatic, peritoneal dissemination, pleural dissemination, and locoregional in 15 (11.3%), 20 (15.1%), 3 (2.3%), 4 (3.0%), and 5 patients (3.8%), respectively. The rate of regional lymph node recurrence within the dissection field was only 4.5%. The prognosis of patients with lymph node metastasis was significantly poorer than that of patients without lymph node metastasis. However, the prognosis of the 11 cases that had metastasis only around RLNs was similar to that of node‐negative cases. Thirteen patients with pathological remnant tumor (R1 or R2) did not survive longer than 5 years at present. The overall 5‐year survival rate of stage I, II, and III disease after curative VATS was 82.2%, 77.0%, and 52.3%, respectively. Expansion of VATS criteria for patients after induction chemotherapy for T4 tumor or thoracoscopic anastomosis did not adversely affect the surgical results by experience. Although the VATS procedure is accompanied by a certain degree of morbidity including RLN palsy and pulmonary complications, VATS has an excellent locoregional control effect. In addition, the favorable survival after VATS shows that the procedure is oncologically feasible. 相似文献
62.
Masashi Ninomiya Yasuteru Kondo Tetsuya Niihori Takeshi Nagashima Takayuki Kogure Eiji Kakazu Osamu Kimura Yoko Aoki Yoichi Matsubara Tooru Shimosegawa 《Hepatology research》2014,44(6):678-684
Taking nucleoside/nucleotide analogs is a major antiviral therapy for chronic hepatitis B infection. The problem with this treatment is the selection for drug‐resistant mutants. Currently, identification of genotypic drug resistance is conducted by molecular cloning sequenced by the Sanger method. However, this methodology is complicated and time‐consuming. These limitations can be overcome by deep sequencing technology. Therefore, we performed sequential analysis of the frequency of drug resistance in one individual, who was treated with lamivudine on‐and‐off therapy for 2 years, by deep sequencing. The lamivudine‐resistant mutations at rtL180M and rtM204V and the entecavir‐resistant mutation at rtT184L were detected in the first subject. The lamivudine‐ and entecavir‐resistant strain was still detected in the last subject. However, in the deep sequencing analysis, rt180 of the first subject showed a mixture in 76.9% of the methionine and in 23.1% of the leucine, and rt204 also showed a mixture in 69.0% of the valine and 29.8% of the isoleucine. During the treatment, the ratio of resistant mutations increased. At rt184, the resistant variants were detectable in 58.7% of the sequence, with the replacement of leucine by the wild‐type threonine in the first subject. Gradually, entecavir‐resistant variants increased in 82.3% of the leucine in the last subject. In conclusion, we demonstrated the amino acid substitutions of the serial nucleoside/nucleotide analog resistants. We revealed that drug‐resistant mutants appear unchanged at first glance, but actually there are low‐abundant mutations that may develop drug resistance against nucleoside/nucleotide analogs through the selection of dominant mutations. 相似文献
63.
Koichi Okamoto Itasu Ninomiya Shogo Maruzen Hiroto Saito Tomoya Tsukada Jun Kinoshita Isamu Makino Keishi Nakamura Katsunobu Oyama Tomoharu Miyashita Hidehiro Tajima Hiroyuki Takamura Hirohisa Kitagawa Sachio Fushida Takashi Fujimura Tetsuo Ohta 《Esophagus》2014,11(2):89-98
Background
Tachyarrhythmia after esophagectomy is a severe complication that should not be underestimated because of its negative impact. The aims of this study were to clarify the cause and impact of postoperative tachyarrhythmia after thoracoscopic esophagectomy. Additionally, we analyzed the usefulness of landiolol administration for postoperative tachyarrhythmia.Methods
We evaluated the predictive factors for tachyarrhythmia onset after surgery and its clinical impact in 127 patients who underwent thoracoscopic esophagectomy with extended lymphadenectomy. Moreover, we analyzed the efficacy of landiolol for postoperative tachyarrhythmia.Results
Tachyarrhythmia developed in 38 of the 127 patients. Multivariate analysis showed that advanced age, heart disease, and hyperlipidemia were associated with postoperative tachyarrhythmia. Hyponatremia, hypoalbuminemia, and leukocytosis on postoperative day 3 were significantly associated with tachyarrhythmia onset. The incidence of all complications and respiratory complications, including pneumonia, was significantly higher in patients with than in those without tachyarrhythmia. The mortality rate in the tachyarrhythmia group tended to be higher than that in the nontachyarrhythmia group. Landiolol as a treatment for tachyarrhythmia immediately decreased heart rate and safely reduced subsequent respiratory complications.Conclusion
In elderly patients with cardiac disease or hyperlipidemia, surgeons should be alert for the occurrence of tachyarrhythmia after esophagectomy. Postoperative tachyarrhythmia is a marker of morbidities with particular emphasis on respiratory complications. However, it can be adequately managed by landiolol, resulting in fewer respiratory complications. Landiolol might be a safe and convenient agent for managing postoperative tachyarrhythmia after thoracoscopic esophagectomy, resulting in lower mortality and morbidity rates. 相似文献64.
Miku Nakagawa Riko Kitazawa Takeshi Kondo Kosuke Ninomiya Masayoshi Okita Ryuma Haraguchi Sohei Kitazawa 《Virchows Archiv : an international journal of pathology》2014,464(3):253-256
Duodenal gastric heterotopia (DGH) is a benign asymptomatic condition assumed to be of congenital origin. Since DGH is often associated with fundic gland polyps (FGPs) that frequently carry a somatic β-catenin gene mutation, we examined whether DGH, either sporadic or FGP-associated, is attributable to alterations of the Wnt/β-catenin pathway. Genetic analysis revealed frequent somatic β-catenin gene mutations in DGH; some of which showed the same mutation pattern as coexisting FGPs. All missense mutations were confined to codons 32, 33, and 37. No such mutations were observed, however, in any of the specimens from focal gastric foveolar metaplasia (GFM). Therefore, DGH is not a mere congenital lesion due to aberrant migration of normal gastric mucosa or a simple reactive metaplasia after regenerative stimuli of the duodenal mucosa, but a distinct condition based upon molecular genetic changes in the Wnt/β-catenin pathway. 相似文献
65.
Yoshinao Ohbatake Isamu Makino Hirohisa Kitagawa Shinichi Nakanuma Hironori Hayashi Hisatoshi Nakagawara Tomoharu Miyashita Hidehiro Tajima Hiroyuki Takamura Itasu Ninomiya Sachio Fushida Takashi Fujimura Tetsuo Ohta 《Clinical journal of gastroenterology》2014,7(3):265-270
Pancreatic schwannoma is a very rare tumor that tends to be confused with other pancreatic tumors preoperatively. We report a case of schwannoma of the pancreatic head. A 40-year-old woman was admitted to our hospital for treatment of a pancreatic tumor which was found by medical checkup. It was a well-defined solid tumor exhibiting heterogeneous enhancement with some necrotic foci on contrast-enhanced computed tomography (CT) and on magnetic resonance imaging (MRI). Angiography and CT during arteriography revealed the main feeding arteries of the tumor to be the posterior and anterior superior pancreaticoduodenal arteries. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) showed accumulation of FDG in the tumor with a maximum standardized uptake value of 3.6. We diagnosed a solid pseudopapillary neoplasm or a pancreatic neuroendocrine tumor preoperatively and performed pylorus-preserving pancreaticoduodenectomy. The tumor had well a well-defined capsule and was composed of a large solid portion containing spindle cells and a smaller hemorrhagic portion containing hypocellular stroma, and diagnosed as pancreatic schwannoma by immunohistochemistry. In this case, CT during arteriography was useful in determining the origin of the tumor. MRI reflected the pathological features of the tumor. The most important finding was that FDG-PET showed abnormal accumulation of FDG in the benign pancreatic schwannoma. 相似文献
66.
Zoungas S Chalmers J Ninomiya T Li Q Cooper ME Colagiuri S Fulcher G de Galan BE Harrap S Hamet P Heller S MacMahon S Marre M Poulter N Travert F Patel A Neal B Woodward M;ADVANCE Collaborative Group 《Diabetologia》2012,55(3):636-643
Aims/hypothesis
There is conflicting evidence regarding appropriate glycaemic targets for patients with type 2 diabetes. Here, we investigate the relationship between HbA1c and the risks of vascular complications and death in such patients.Methods
Eleven thousand one hundred and forty patients were randomised to intensive or standard glucose control in the Action in Diabetes and Vascular disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Glycaemic exposure was assessed as the mean of HbA1c measurements during follow-up and prior to the first event. Adjusted risks for each HbA1c decile were estimated using Cox models. Possible differences in the association between HbA1c and risks at different levels of HbA1c were explored using linear spline models.Results
There was a non-linear relationship between mean HbA1c during follow-up and the risks of macrovascular events, microvascular events and death. Within the range of HbA1c studied (5.5?C10.5%), there was evidence of ??thresholds??, such that below HbA1c levels of 7.0% for macrovascular events and death, and 6.5% for microvascular events, there was no significant change in risks (all p?>?0.8). Above these thresholds, the risks increased significantly: every 1% higher HbA1c level was associated with a 38% higher risk of a macrovascular event, a 40% higher risk of a microvascular event and a 38% higher risk of death (all p?0.0001).Conclusions/interpretation
In patients with type 2 diabetes, HbA1c levels were associated with lower risks of macrovascular events and death down to a threshold of 7.0% and microvascular events down to a threshold of 6.5%. There was no evidence of lower risks below these levels but neither was there clear evidence of harm.Trial Registration:
ClinicalTrial.gov NCT00145925Funding:
Servier and the National Health and Medical Research Council of Australia (project grant ID 211086 and programme grant IDs 358395 and 571281) 相似文献67.
Ichiki H Oketani N Ishida S Iriki Y Okui H Maenosono R Ninomiya Y Matsushita T Miyata M Hamasaki S Tei C 《Journal of cardiovascular electrophysiology》2012,23(6):567-573
Cerebral Microthromboembolism After CFAE Ablation . Background: The incidence of cerebral thromboembolism after pulmonary vein isolation (PVI) ranges from 2% to 14%. This study investigated the incidence of cerebral thromboembolism after complex fractionated atrial electrogram (CFAE) ablation with or without PVI. Methods: One hundred consecutive atrial fibrillation (AF) patients (50 paroxysmal and 50 persistent, including 10 longstanding) who underwent CFAE ablation combined with (n = 41, PVI+CFAE group) or without (n = 59, CFAE group) PVI were studied. Coronary angiography (CAG) was conducted with AF ablation in 5 cases in which coronary artery stenosis was suspected on 3D‐computed tomography. PVI was performed before CFAE ablation without circular catheter during AF. After termination of AF, additional ablation was performed to complete PVI with a circular catheter. All patients underwent cerebral magnetic resonance imaging (MRI) including diffusion‐weighted MRI and T2‐weighted MRI the day after ablation. Results: New thromboembolism was detected in 7.0%, and there was no significant difference between the 2 strategies (7.3% in PVI+CFAE group, 6.8% in CFAE group). CHADS2 score (1.6 ± 1.0 vs 0.8 ± 0.9, P < 0.05), left atrial volume (LAV; 83.8 ± 27.1 vs 67.8 ± 21.8, P < 0.05), and left ventricular ejection fraction (LVEF, 53.1 ± 9.2 vs 65.1 ± 9.7, P < 0.01) were significantly different when comparing patients with or without thromboembolism. In multivariate analysis, LVEF (odds ratio [OR], 0.92; 95% confidence interval [CI], 0.84–0.99; P < 0.05) and concomitant CAG (OR 18.82; 95% CI, 1.77–200.00; P < 0.05) were important predictors of new cerebral thromboembolism. Conclusions: The incidence of cerebral microthromboembolism after CFAE ablation was not greater than previous reports in PVI. Cautious management is required during AF ablation, especially in the patients with low LVEF. (J Cardiovasc Electrophysiol, Vol. 23, pp. 567–573, June 2012) 相似文献
68.
Hirotomo Ninomiya Toshiki Yoshimine Motohiko Maruno Amami Kato Toru Hayakawa 《Neurological research》2013,35(6):526-528
AbstractThe ventriculo-peritoneal shunt placed in a neonate or infant needs revision to lengthen the peritoneal tube at certain times during childhood. The critical time for this revision is not exactly the same between individuals. Furthermore, the level of peritoneal insertion of the shunt tube is often unclear on x-ray films. To plan for and determine the optimal timing of revision, we applied a titanium clip on the peritoneal suture line in three infants as a marker of peritoneal insertion level. During the 31- to 37-month follow-up period, abdominal x-ray clearly demonstrated the peritoneal insertion level in all three patients, allowing accurate determination of the length of the intraperitoneal portion OP) of the shunt tube. The rate of shortening of the length of IP was 20 to 27% of the increase in body height (BH). This technique allows accurate determination of the length of IP and also optimal timing for revision. [Neural Res 1998; 20: 526-528] 相似文献
69.
Motohiko Maruno Toshiki Yoshimine Ghulam Muhammad Hirotomo Ninomiya Toru Hayakawa 《Neurological research》2013,35(7):612-616
AbstractWe investigated chromosomal aberrations in meningiomas using newly developed comparative genomic hybridization (CGH) technique and compared the results with the proliferating potential of the tumors. This technique permits the entire genome to be surveyed in one session of experiments. Our results revealed chromosomal aberrations in 5 out of 10 (50%) of the tumor samples studied. Losses of the distal parts of chromosome 1p (5 out of 10) and 22q (3 out of 10) were the two most frequent chromosomal aberrations. Losses and/or gains in other regions were only sporadic. The MIB-1 staining indices (MIB-511 %) were 1.9 ± 0.9% (mean ± SD) in benign (n = 8)1 4.5% in atypical (n = 1)1 and 11.7% in anaplastic (n = 1) meningiomas. The comparison of MIB-51 between the tumors with (2.3 ± 0.6%) and without (7.6 ± 0.3%) chromosomal aberrations demonstrated a trend towards an increased MIB-51 in meningiomas with chromosomal aberrations (p < 0.07) by unpaired 5tudent1s t-test. This study suggests that alterations in chromosomes 1p and 22q could be a primary focus of further detailed assessment of tumorigenesis and in understanding the biological behavior of meningiomas. [Neural Res 1998; 20: 612-616] 相似文献
70.
Hiroaki Hanada Junko Imanaga Aoi Yoshiiwa Tomoya Yoshikawa Yoshihiro Tanaka Jusen Tsuru Ayako Inoue Yoshinobu Ishitobi Shizuko Okamoto Masayuki Kanehisa Yoshihiro Maruyama Taiga Ninomiya Haruka Higuma Koichi Isogawa Tsuyoshi Kawasaki Toshio Fujioka Jotaro Akiyoshi 《International journal of geriatric psychiatry》2013,28(7):756-765